CN110538362A - Application of nutrient solution in preparation of medicine for treating lymphatic stasis regional disease symptoms - Google Patents
Application of nutrient solution in preparation of medicine for treating lymphatic stasis regional disease symptoms Download PDFInfo
- Publication number
- CN110538362A CN110538362A CN201910194569.9A CN201910194569A CN110538362A CN 110538362 A CN110538362 A CN 110538362A CN 201910194569 A CN201910194569 A CN 201910194569A CN 110538362 A CN110538362 A CN 110538362A
- Authority
- CN
- China
- Prior art keywords
- nutrient solution
- parts
- treating
- blocking area
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/08—Devices for applying needles to such points, i.e. for acupuncture ; Acupuncture needles or accessories therefor
- A61H39/086—Acupuncture needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rehabilitation Therapy (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
The application discloses an application of a nutrient solution in preparation of a medicine for treating a lymphatic stasis regional disease symptom, wherein the nutrient solution comprises the following raw material components in parts by weight: 1-3 parts of medical collagen filling agent, 2-6 parts of astragalus injection, 2-6 parts of compound angelica injection and 100-300 parts of normal saline. By applying the nutrient solution in preparation of the medicine for treating the disease symptoms of the lymph stasis blocking area, the nutrient solution is injected into the lymph stasis blocking area, and the application of rapidly removing toxins and removing stasis blocks in the medicine for treating the disease symptoms is realized.
Description
Technical Field
The application relates to the field of communication, in particular to application of the compound in preparing a medicine for treating the disease symptoms of a lymph stasis blocking area.
Background
The lymphatic system is an important defense function system in the human body, and is distributed throughout the whole body, with 7 and 800 lymph nodes. The lymphatic system, on the one hand, drains lymph fluid and removes foreign matters, bacteria and the like in the body. On the other hand, the lymphatic system is a sentinel of body defense, and is dispersed in lymph nodes of various parts of the body like a filtering device, so that microorganisms entering through lymphatic vessels can be effectively prevented. More and more people pay attention to the toxin which is a main source of health hazard, and the lymphatic system plays an important role in the detoxification of human bodies.
In a healthy human body, about one billion lymphocytes are active, and the lymphocytes are classified into T lymphocytes and B lymphocytes. Both are derived from bone marrow, but T cells are formed in the thymus, whose primary function is to phagocytose foreign invaders. The most important function of B cells is to produce a wide variety of antibodies, like weapons within teams, in order to defend us against foreign invaders. The lymphatic circulation gives the toxin sufficient opportunity to contact the surface of the powerful detoxifying cells of the human body. More than 99% of the soluble toxins and metabolic waste products can be removed by the lymphatic system. If accumulated toxins are the root cause of disease, detoxification construction is the starting point for health. The lymphatic system of the human body is very massive, with shoulder and neck, axillary and inguinal lymphatics being the most responsive to health.
After the age of 30, people are easy to get good fortune, namely, people are fat in body type and have a middle-aged posture. The main reasons are the slowing of microcirculation, lymph stasis and blockage, and unsmooth channels and collaterals. Careful observation reveals that these sites of stasis and fatness are all around the lymph nodes.
Aiming at the problem that the application of the medicine for treating disease symptoms of toxin expelling, stasis removing and blockage removing by combining water injection with nutrient solution is lacked in the related technology, an effective solution is not provided at present.
Disclosure of Invention
The application mainly aims to provide an application of the medicine in preparing the disease symptoms of the lymph stasis blocking area, so as to solve the problem of lacking the medicine capable of detoxifying and removing the stasis blocking disease symptoms by combining a water needle with a nutrient solution.
In order to achieve the above object, according to one aspect of the present application, there is provided a use of a nutrient solution as a medicament for preparing a symptom of a disorder in a region of lymphatic stasis.
According to the application of the nutrient solution in preparing the medicine for treating the disease symptoms of the lymph stasis blocking area, the nutrient solution is injected into the lymph stasis blocking area and comprises the following raw material components in parts by weight: 1-3 parts of medical collagen filling agent, 2-6 parts of astragalus injection, 2-6 parts of compound angelica injection and 100-300 parts of normal saline.
Further, the nutrient solution is injected into the lymph stasis blocking area through a water needle, and the method comprises the following steps:
Determining an injection position: selecting the position of the lymph stasis blocking area as an injection position;
Skin disinfection: disinfecting the skin at the injection site with a sterile cotton swab;
Liquid medicine injection: and (3) holding the injector containing the nutrient solution by hand, evacuating air, aligning the needle point with the injection position, quickly puncturing the subcutaneous part, slowly inserting the needle to the needle insertion depth, slowly injecting the nutrient solution, pulling out the needle head of the injector after the nutrient solution is injected, and lightly pressing by using a sterile cotton swab to finish injection.
further, injecting a nutrient solution into the lymphangiostasis region comprises: and (4) injecting nutrient solution into the inguinal lymph stasis blocking area.
Further, injecting a nutrient solution into the lymphangiostasis region comprises: and (4) injecting nutrient solution into the shoulder and neck lymph stasis area.
Further, injecting a nutrient solution into the lymphangiostasis region comprises: and (4) injecting nutrient solution into the axillary lymph stasis blocking area.
Further, the medical collagen filler is a physiological saline suspension of 3.5% of bovine collagen and 0.3% of lidocaine hydrochloride.
Furthermore, the volume of the water needle when the water needle acupuncture and moxibustion is carried out on the acupuncture points of the lymph stasis blocking area at one time is not more than 120 ml.
Further, the water injection is prepared for use at present.
The nutrient solution is used for preparing the medicine for treating the disease symptoms of the lymph stasis blocking area, the nutrient solution is injected into the lymph stasis blocking area, and the compound nutrient solution rich in collagen, Chinese angelica injection and normal saline is injected into the lymph stasis blocking area, wherein the collagen increases the compactness and elasticity of the skin and tensions the skin. The angelica can enrich and activate blood, accelerate blood and lymph circulation, quickly remove toxin and remove stasis and blockage.
Detailed Description
In order to make the technical solutions of the present application better understood by those skilled in the art, the technical solutions in the embodiments of the present application will be clearly and completely described below in conjunction with the embodiments of the present application, and it is obvious that the described embodiments are only some embodiments of the present application, but not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present application.
It should be noted that the embodiments and features of the embodiments in the present application may be combined with each other without conflict. The present application will be described in detail with reference to examples.
Example 1
The nutrient solution is applied to preparing a medicine for treating the disease symptoms of the lymph stasis blocking area, and the nutrient solution is injected into the lymph stasis blocking area and comprises the following raw material components in parts by weight: 1-3 parts of medical collagen filling agent, 2-6 parts of astragalus injection, 2-6 parts of compound angelica injection and 100-300 parts of normal saline. The method for injecting the nutrient solution into the lymph stasis blocking area through the water needle comprises the following steps: determining an injection position: selecting the position of the lymph stasis blocking area as an injection position; skin disinfection: disinfecting the skin at the injection site with a sterile cotton swab; liquid medicine injection: and (3) holding the injector containing the nutrient solution by hand, evacuating air, aligning the needle point with the injection position, quickly puncturing the subcutaneous part, slowly inserting the needle to the needle insertion depth, slowly injecting the nutrient solution, pulling out the needle head of the injector after the nutrient solution is injected, and lightly pressing by using a sterile cotton swab to finish injection. And (4) injecting nutrient solution into the inguinal lymph stasis blocking area. The medical collagen filler is a physiological saline suspension of 3.5 percent of bovine collagen and 0.3 percent of lidocaine hydrochloride. The volume of the water needle when the water needle acupuncture and moxibustion is carried out on the acupuncture points of the lymph stasis blocking area at one time is not more than 120 ml. The water injection is prepared for use.
Example 2
The nutrient solution is applied to preparing a medicine for treating the disease symptoms of the lymph stasis blocking area, and the nutrient solution is injected into the lymph stasis blocking area and comprises the following raw material components in parts by weight: 1-3 parts of medical collagen filling agent, 2-6 parts of astragalus injection, 2-6 parts of compound angelica injection and 100-300 parts of normal saline. The method for injecting the nutrient solution into the lymph stasis blocking area through the water needle comprises the following steps: determining an injection position: selecting the position of the lymph stasis blocking area as an injection position; skin disinfection: disinfecting the skin at the injection site with a sterile cotton swab; liquid medicine injection: and (3) holding the injector containing the nutrient solution by hand, evacuating air, aligning the needle point with the injection position, quickly puncturing the subcutaneous part, slowly inserting the needle to the needle insertion depth, slowly injecting the nutrient solution, pulling out the needle head of the injector after the nutrient solution is injected, and lightly pressing by using a sterile cotton swab to finish injection. And (4) injecting nutrient solution into the shoulder and neck lymph stasis area. The medical collagen filler is a physiological saline suspension of 3.5 percent of bovine collagen and 0.3 percent of lidocaine hydrochloride. The volume of the water needle when the water needle acupuncture and moxibustion is carried out on the acupuncture points of the lymph stasis blocking area at one time is not more than 120 ml. The water injection is prepared for use.
Example 3
The nutrient solution is applied to preparing a medicine for treating the disease symptoms of the lymph stasis blocking area, and the nutrient solution is injected into the lymph stasis blocking area and comprises the following raw material components in parts by weight: 1-3 parts of medical collagen filling agent, 2-6 parts of astragalus injection, 2-6 parts of compound angelica injection and 100-300 parts of normal saline. The method for injecting the nutrient solution into the lymph stasis blocking area through the water needle comprises the following steps: determining an injection position: selecting the position of the lymph stasis blocking area as an injection position; skin disinfection: disinfecting the skin at the injection site with a sterile cotton swab; liquid medicine injection: and (3) holding the injector containing the nutrient solution by hand, evacuating air, aligning the needle point with the injection position, quickly puncturing the subcutaneous part, slowly inserting the needle to the needle insertion depth, slowly injecting the nutrient solution, pulling out the needle head of the injector after the nutrient solution is injected, and lightly pressing by using a sterile cotton swab to finish injection. And (4) injecting nutrient solution into the axillary lymph stasis blocking area. The medical collagen filler is a physiological saline suspension of 3.5 percent of bovine collagen and 0.3 percent of lidocaine hydrochloride. The volume of the water needle when the water needle acupuncture and moxibustion is carried out on the acupuncture points of the lymph stasis blocking area at one time is not more than 120 ml. The water injection is prepared for use.
Example 4
The nutrient solution is applied to preparing a medicine for treating the disease symptoms of the lymph stasis blocking area, and the nutrient solution is injected into the lymph stasis blocking area and comprises the following raw material components in parts by weight: 1 part of medical collagen filling agent, 2 parts of astragalus injection, 2 parts of compound angelica injection and 100 parts of normal saline. The medical collagen filler is a physiological saline suspension of 3.5 percent of bovine collagen and 0.3 percent of lidocaine hydrochloride. The volume of the water needle when the water needle acupuncture and moxibustion is carried out on the acupuncture points of the lymph stasis blocking area at one time is not more than 120 ml. The water injection is prepared for use.
Example 5
The nutrient solution is applied to preparing a medicine for treating the disease symptoms of the lymph stasis blocking area, and the nutrient solution is injected into the lymph stasis blocking area and comprises the following raw material components in parts by weight: 3 parts of medical collagen filling agent, 6 parts of astragalus injection, 6 parts of compound angelica injection and 300 parts of normal saline. The medical collagen filler is a physiological saline suspension of 3.5 percent of bovine collagen and 0.3 percent of lidocaine hydrochloride. The volume of the water needle when the water needle acupuncture and moxibustion is carried out on the acupuncture points of the lymph stasis blocking area at one time is not more than 120 ml. The water injection is prepared for use.
Experiments and researches on injecting nutrient solution into the lymph stasis blocking area by taking volunteers as test objects investigate the influence of the nutrient solution injected into the lymph stasis blocking area in the embodiments 1-4 on toxin expelling, stasis removing and blocking. The specific operation method is as follows:
Injecting a compound nutrient solution rich in collagen, angelica injection and normal saline into the area of lymph stasis blockage, wherein the collagen increases the compactness and elasticity of the skin and strains the skin. The angelica can enrich and activate blood, accelerate blood and lymph circulation, quickly remove toxin and remove stasis and blockage. Dredging channels and collaterals, invigorating qi and blood, relieving the burden of five internal organs, and achieving the effects of coordinating yin and yang balance and shaping perfect body shape.
TABLE 1 detoxification, stasis removal and blockage removal test of hydro-acupuncture combined nutrient solution
| symptoms before use | Whether to expel toxin and remove blood stasis | |
| Example 1 | Obesity of lower limbs and numbness of legs and feet | Is and the effect is obvious |
| Example 2 | scapulohumeral periarthritis, shoulder and neck pain | Is and the effect is obvious |
| Example 3 | Chest pain and distention | Is and the effect is obvious |
| Example 4 | Scapulohumeral periarthritis, shoulder and neck pain | Is, and the effect is not obvious |
| Example 5 | scapulohumeral periarthritis, shoulder and neck pain | Is and the effect is obvious |
The above description is only a preferred embodiment of the present application and is not intended to limit the present application, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, improvement and the like made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims (5)
1. An application of a nutrient solution in preparing a medicament for treating a disease symptom of a lymph stasis blocking area is characterized by comprising the following components: the nutrient solution comprises the following raw material components in parts by weight: 1-3 parts of medical collagen filling agent, 2-6 parts of astragalus injection, 2-6 parts of compound angelica injection and 100-300 parts of normal saline.
2. The use of the nutritional solution of claim 1 for the preparation of a medicament for treating a condition associated with a disorder of the lymphangiogenic region, wherein injecting the nutritional solution into the lymphangiogenic region comprises: and (4) injecting nutrient solution into the inguinal lymph stasis blocking area.
3. The use of the nutritional solution of claim 1 for the preparation of a medicament for treating a condition associated with a disorder of the lymphangiogenic region, wherein injecting the nutritional solution into the lymphangiogenic region comprises: and (4) injecting nutrient solution into the shoulder and neck lymph stasis area.
4. The use of the nutritional solution of claim 1 for the preparation of a medicament for treating a condition associated with a disorder of the lymphangiogenic region, wherein injecting the nutritional solution into the lymphangiogenic region comprises: and (4) injecting nutrient solution into the axillary lymph stasis blocking area.
5. The use of the nutritional solution according to claim 1 for the preparation of a medicament for the treatment of a condition associated with lymphatic stasis, wherein the medical collagen bulking agent is a physiological saline suspension of 3.5% bovine collagen and 0.3% lidocaine hydrochloride.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910194569.9A CN110538362A (en) | 2019-03-14 | 2019-03-14 | Application of nutrient solution in preparation of medicine for treating lymphatic stasis regional disease symptoms |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910194569.9A CN110538362A (en) | 2019-03-14 | 2019-03-14 | Application of nutrient solution in preparation of medicine for treating lymphatic stasis regional disease symptoms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110538362A true CN110538362A (en) | 2019-12-06 |
Family
ID=68702679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910194569.9A Pending CN110538362A (en) | 2019-03-14 | 2019-03-14 | Application of nutrient solution in preparation of medicine for treating lymphatic stasis regional disease symptoms |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110538362A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115581761A (en) * | 2022-09-27 | 2023-01-10 | 深圳市科医美医疗投资有限公司 | Liquid medicine for injection in lymph stasis blocking area and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1634250A (en) * | 2004-10-18 | 2005-07-06 | 四川乐山三民药物科技开发有限公司 | Compound injectio of Chinese angelica and astragalus root and its preparing process |
| CN101474242B (en) * | 2009-01-25 | 2011-04-27 | 梁丽红 | Medicament for treating cervical vertebra and lumbar vertebra diseases without operation |
| CN105031726A (en) * | 2015-09-02 | 2015-11-11 | 长春博泰医药生物技术有限责任公司 | Medical collagen filling agent |
| CN105535333A (en) * | 2016-02-02 | 2016-05-04 | 王钰微 | Traditional Chinese medicine composition and preparation for treating lymphatic lesions, as well as preparation method and application thereof |
| CN109248238A (en) * | 2017-07-14 | 2019-01-22 | 苏丽 | A kind of preparation and its application of lympha toxin expelling healthy liquid |
-
2019
- 2019-03-14 CN CN201910194569.9A patent/CN110538362A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1634250A (en) * | 2004-10-18 | 2005-07-06 | 四川乐山三民药物科技开发有限公司 | Compound injectio of Chinese angelica and astragalus root and its preparing process |
| CN101474242B (en) * | 2009-01-25 | 2011-04-27 | 梁丽红 | Medicament for treating cervical vertebra and lumbar vertebra diseases without operation |
| CN105031726A (en) * | 2015-09-02 | 2015-11-11 | 长春博泰医药生物技术有限责任公司 | Medical collagen filling agent |
| CN105535333A (en) * | 2016-02-02 | 2016-05-04 | 王钰微 | Traditional Chinese medicine composition and preparation for treating lymphatic lesions, as well as preparation method and application thereof |
| CN109248238A (en) * | 2017-07-14 | 2019-01-22 | 苏丽 | A kind of preparation and its application of lympha toxin expelling healthy liquid |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115581761A (en) * | 2022-09-27 | 2023-01-10 | 深圳市科医美医疗投资有限公司 | Liquid medicine for injection in lymph stasis blocking area and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2369810A1 (en) | Method of treating pain | |
| CN110538362A (en) | Application of nutrient solution in preparation of medicine for treating lymphatic stasis regional disease symptoms | |
| CN110604834A (en) | Application of hydro-acupuncture liquid medicine in preparation of medicine for treating lymph stasis and obstruction areas | |
| CN100490847C (en) | Medicine liquid for treating burns and scalds and its preparation | |
| CN110368583A (en) | A kind of drainage with medicated thread therapeutic device | |
| CN107998286A (en) | A kind of Chinese medicine koro gel and preparation method thereof | |
| CN110559484A (en) | Application of liquid medicine in preparing medicine for improving body shape and posture symptoms | |
| CN105616146A (en) | Blood-letting puncture method for treating urticaria | |
| CN110743037A (en) | Application of hydro-acupuncture liquid medicine in preparing medicine for relieving shoulder and neck disease symptoms | |
| CN110393796A (en) | A kind of externally applied ointment and preparation method thereof for treating bone joint pain | |
| Zhang et al. | Therapeutic observation of ‘warming-unblocking needling technique’for knee osteoarthritis due to deficiency of liver and kidney | |
| CN104257967B (en) | A kind of Chinese medicine for treating injury gained in sports | |
| RU2773101C1 (en) | Method for treating lateral epicondylitis | |
| KR102335712B1 (en) | Composition for lipolysis and injection apparatus thereof | |
| CN106822716A (en) | A kind of exterior-applied medical wine for treating rheumatic spur | |
| HAN et al. | 30 cases of popliteal cyst treated by fire needling and cupping therapy | |
| Cartier | Pressotherapy with adjustable high-pressure gradients | |
| KR20050116674A (en) | Human body administration gold thread and disposable gold thread syringe for curing disease using gold thread | |
| CN103845464A (en) | Decay-removing and new muscle generating powder for treating burning and scald and preparation method and application method thereof | |
| Sha | Clinical observation of acupuncture, stone scraping plus cupping therapy for neck-type cervical spondylosis | |
| Fu et al. | Preventing Lower Extremity Deep Vein Thrombosis After Hip Fracture Surgery in Elderly Patients by Acupoint Application Combined with Pneumatic Compression Therapy | |
| Hou et al. | Auricular Acupoint Threading Combined with Row Needling Method for Nerve Root Type Cervical Spondylosis. | |
| CN104208206A (en) | Medicinal liquor capable of treating rheumatism and ostalgia | |
| Hoyos et al. | Postoperative care | |
| CN101428126A (en) | Externally used medicinal liquor for massaging spondyle |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |